Essentials in Buprenorphine Prescriptions - Live Webinar on September 24, 2025 at 10AM ET
Learn to address the unmet needs of patients with substance use disorders. This course explores buprenorphine prescribing post X-waiver, providing essential knowledge for healthcare professionals to confidently contribute to opioid use disorder (OUD) treatment. Bridging gaps in understanding, it combines didactic instruction and case-based discussions to empower practitioners in expanding care access.
About this webinar
Patients with substance use disorders (SUD) represent an underserved demographic, often lacking access to qualified healthcare providers for their specialized needs. The recent removal of the X-waiver for buprenorphine prescribing in opioid use disorder (OUD) opens new avenues for medical practitioners to contribute to solving this crisis. Despite this regulatory easing, reluctance persists among providers largely due to gaps in knowledge surrounding buprenorphine’s pharmacology, prescribing guidelines, and management.
This course aims to bridge that knowledge gap by covering the fundamentals of buprenorphine prescribing and its outcomes. Using a blend of didactic instruction and case-based discussions, the course empowers healthcare professionals to confidently integrate buprenorphine into their practice, thereby expanding treatment access for this vulnerable patient population.
At the conclusion of this continuing education activity, the participant will be able to:
Identify the current gaps in care for the treatment of patients with opioid use disorder (OUD)
Describe current treatment recommendations, including non-pharmacologic options, when treating patients with opioid use disorder, with a focus on buprenorphine prescribing
Discuss pertinent monitoring and legal responsibilities for the use of buprenorphine therapy for patients with OUD
